1. Home
  2. NODK vs CERS Comparison

NODK vs CERS Comparison

Compare NODK & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NODK

NI Holdings Inc.

HOLD

Current Price

$13.07

Market Cap

265.8M

Sector

Finance

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.02

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NODK
CERS
Founded
1946
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
265.8M
276.0M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
NODK
CERS
Price
$13.07
$2.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.2K
951.7K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
$285,050,000.00
$51,326,000.00
Revenue This Year
N/A
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$12.01
$1.15
52 Week High
$14.70
$2.96

Technical Indicators

Market Signals
Indicator
NODK
CERS
Relative Strength Index (RSI) 52.23 55.50
Support Level $13.03 $1.89
Resistance Level $13.73 $2.15
Average True Range (ATR) 0.23 0.10
MACD 0.02 0.01
Stochastic Oscillator 76.72 59.32

Price Performance

Historical Comparison
NODK
CERS

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. Through its subsidiaries, the company operates in the insurance industry, offering homeowners and farmowners insurance policies, crop insurance policies, home insurance policies, etc. These insurance products are distributed through a network of exclusive and independent agents across the United States. The group's reportable segments are: Private Passenger Auto, Non-Standard Auto, Home and Farm, Crop, and All Other (which mainly consists of commercial, assumed reinsurance, and its excess liability business). Maximum revenue is generated from the Home and Farm segment.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: